Financials

Discussions Technicals Seasonals

229500 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

NovMetaPharma Co., Ltd. engages in the manufacture and sale of biological drugs for insulin resistance and related metabolic diseases. Its business areas include new medicine development and healthy foods. Its products include medicines for diabetes, obesity, Alzheimer's disease, immunity cure, osteoporosis, and non-alcoholic fatty liver. The company was founded on November 4, 2010 and is headquartered in Seoul, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

229500 does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company